These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21953704

  • 1. Ecstasy use and self-reported disturbances in sleep.
    Ogeil RP, Rajaratnam SM, Phillips JG, Redman JR, Broadbear JH.
    Hum Psychopharmacol; 2011 Oct; 26(7):508-16. PubMed ID: 21953704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C, Fisk JE, Wareing M, Murphy P.
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [Abstract] [Full Text] [Related]

  • 6. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE, Montgomery C, Murphy PN.
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [Abstract] [Full Text] [Related]

  • 7. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.
    J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]

  • 17. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    Engels RC, ter Bogt T.
    Eur Addict Res; 2004 Oct; 10(4):156-62. PubMed ID: 15367816
    [Abstract] [Full Text] [Related]

  • 18. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
    Yen CF, Hsu SY, Cheng CP.
    Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
    [Abstract] [Full Text] [Related]

  • 19. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 20. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ, Bruno R.
    Neuropsychobiology; 2010 Sep; 61(4):215-22. PubMed ID: 20389132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.